Fireside Chat: Next-Gen Drug Delivery: Unlocking Bioavailability, Precision, and Patient-Centric Design

Session details:

At Johnson & Johnson, the future of drug delivery is being shaped by a deep commitment to patient-centered design. From improving bioavailability and precision to making treatments more accessible and less disruptive, J&J is working to redefine how therapies are developed and delivered. This approach recognizes that even the most effective treatments must also fit into patients’ real lives—recognizing their preferences, comfort, and daily routines.

In this session, J&J’s Chris Cutie will explore:

Why patient needs and lifestyle should be central to drug delivery innovation
Best practices for engaging patients early in the design and development process
Strategies for fostering ongoing collaboration between patients, providers, and industry to ensure treatments are truly built for those who use them